Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,184,865 papers from all fields of science
Search
Sign In
Create Free Account
dihydrocyclosporin C
Known as:
Cyclosporin A, 6-((3R,4R)-3-hydroxy-N,4-dimethyl-L-2-aminooctanoic acid)-7-L-threonine-
, Cyclosporin A, 6-((R-(R*,R*))-3-hydroxy-N,4-dimethyl-L-2-aminooctanoic acid)-7-L-threonine-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Cyclosporins
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Discovery of Small-Molecule Nonfluorescent Inhibitors of Fluorogen–Fluorogen Activating Protein Binding Pair
Yang Wu
,
S. Stauffer
,
+15 authors
L. Sklar
Journal of biomolecular screening
2016
Corpus ID: 1694268
A new class of biosensors, fluorogen activating proteins (FAPs), has been successfully used to track receptor trafficking in live…
Expand
2008
2008
N,4-Dimethyl-N-(4-nitrobenzyl)benzenesulfonamide
Hong Zhu
,
Z. Wu
,
Shende Jiang
Acta Crystallographica Section E
2008
Corpus ID: 263987769
In the title compound, C15H16N2O4S, there is a dihedral angle of 63.30 (8)° between the nitrobenzyl and benzene rings, which are…
Expand
1975
1975
Inhibition of urease activity by hydroxamic acid derivatives of amino acids.
K. Kobashi
,
S. Takebe
,
N. Terashima
,
J. Hase
Journal of Biochemistry (Tokyo)
1975
Corpus ID: 25894044
Hydroxamic acids have been reported to be potent and specific inhibitors of urease (EC 3.5.1.5) activity of plant and bacterial…
Expand
1967
1967
Synthesis of 4-L-valine-6-L-threonine-, 4-L-isoleucine-6-L-threonine-, 4-L-leucine-6-L-threonine-, 4-L-valine-, and 4-L-isoleucine-bradykinin and their O-acetyl compounds.
K. Suzuki
,
T. Abiko
Chemical and pharmaceutical bulletin
1967
Corpus ID: 2264755
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE